Enolase Inhibitors as Early Lead Therapeutics against <i>Trypanosoma brucei</i>

Enolase Inhibitors as Early Lead Therapeutics against <i>Trypanosoma brucei</i>

Glucose metabolism is critical for the African trypanosome, <i>Trypanosoma brucei</i>, serving as the lone source of ATP production for the bloodstream form (BSF) parasite in the glucose-rich environment of the host blood. Recently, phosphonate inhibitors of human enolase (ENO), the enzy...

Full description

Bibliographic Details
Main Authors: Colm P. Roster, Danielle LaVigne, Jillian E. Milanes, Emily Knight, Heidi D. Anderson, Sabrina Pizarro, Elijah M. Harding, Meredith T. Morris, Victoria C. Yan, Cong-Dat Pham, Florian Muller, Samuel Kwain, Kerrick C. Rees, Brian Dominy, Daniel C. Whitehead, Md Nasir Uddin, Steven W. Millward, James C. Morris
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Pathogens
Subjects:
enolase
African trypanosome
glycolysis
inhibitors
<i>Trypanosoma brucei</i>
Online Access:https://www.mdpi.com/2076-0817/12/11/1290

Internet

https://www.mdpi.com/2076-0817/12/11/1290

Similar Items